Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
Move comes amid rising regulatory pressures
Targets high-growth eye care expansion push
Manoj has over two decades of experience in healthcare operations and biomedical engineering
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
